Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
LetterLetters to the Editor

Reply: Breast Cancer Staging: To Which Women Should 18F-FDG PET/CT Be Offered?

Gary A. Ulaner and Christopher C. Riedl
Journal of Nuclear Medicine August 2015, 56 (8) 1293-1294; DOI: https://doi.org/10.2967/jnumed.115.161042
Gary A. Ulaner
*Memorial Sloan Kettering Cancer Center 1275 York Ave., Box 77 New York, NY 10065 E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ulanerg@mskcc.org
Christopher C. Riedl
*Memorial Sloan Kettering Cancer Center 1275 York Ave., Box 77 New York, NY 10065 E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ulanerg@mskcc.org
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 56 no. 8 1293-1294
DOI 
https://doi.org/10.2967/jnumed.115.161042
PubMed 
26112021

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 3, 2015.

Article Versions

  • previous version (June 25, 2015 - 05:28).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

Statistics from Altmetric.com

Cited By...

  • 3 Citations
  • 3 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • 18F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer
    Gary A. Ulaner, Raychel Castillo, Debra A. Goldman, Jonathan Wills, Christopher C. Riedl, Katja Pinker-Domenig, Maxine S. Jochelson, Mithat Gönen
    European Journal of Nuclear Medicine and Molecular Imaging 2016 43 11
  • 18F–FDG-PET/CT for systemic staging of patients with newly diagnosed ER-positive and HER2-positive breast cancer
    Gary A. Ulaner, Raychel Castillo, Jonathan Wills, Mithat Gönen, Debra A. Goldman
    European Journal of Nuclear Medicine and Molecular Imaging 2017 44 9
  • Is PET/CT Necessary in the Management of Early Breast Cancer?
    Gül Nihal Nursal, Tarik Zafer Nursal, Huseyin Ozgur Aytac, Bermal Hasbay, Neşe Torun, Mehmet Reyhan, Ali Fuat Yapar
    Clinical Nuclear Medicine 2016 41 5

Article usage

Article usage: June 2015 to April 2025

AbstractFullPdf
Jun 20151036
Jul 20151033
Aug 2015212473
Sep 201505824
Oct 201504117
Nov 201504120
Dec 201503215
Jan 201604312
Feb 201602211
Mar 2016069
Apr 201601712
May 20160118
Jun 2016044
Jul 2016085
Aug 20160135
Sep 20160125
Oct 20160155
Nov 20160175
Dec 20160131
Jan 20170112
Feb 20170176
Mar 20170152
Apr 2017041
May 20170113
Jun 20170102
Jul 2017012
Aug 2017061
Sep 20170102
Oct 20170125
Nov 2017083
Dec 20170131
Jan 2018095
Feb 2018082
Mar 20180111
Apr 2018084
May 2018091
Jun 20180101
Jul 2018042
Aug 2018060
Sep 2018061
Oct 2018063
Nov 2018044
Dec 2018041
Jan 20190102
Feb 2019063
Mar 2019053
Apr 2019072
May 2019073
Jun 2019072
Jul 2019056
Aug 2019081
Sep 2019075
Oct 2019095
Nov 2019068
Dec 2019064
Jan 2020051
Feb 20200104
Mar 2020086
Apr 2020052
May 2020039
Jun 2020045
Jul 2020061
Aug 2020021
Sep 2020061
Oct 2020085
Nov 2020014
Dec 2020053
Jan 2021032
Feb 20210515
Mar 20210345
Apr 20210202
May 20210164
Jun 2021071
Jul 20210816
Aug 2021086
Sep 2021026
Oct 20210722
Nov 20210713
Dec 20210102
Jan 2022067
Feb 2022081
Mar 2022086
Apr 2022004
May 2022057
Jun 2022076
Jul 20220124
Aug 2022055
Sep 2022038
Oct 2022036
Nov 2022041
Dec 2022063
Jan 2023095
Feb 2023032
Mar 2023066
Apr 20230121
May 2023084
Jun 2023010
Jul 20230510
Aug 2023006
Sep 2023020
Oct 20230312
Nov 2023064
Dec 20230110
Jan 20240121
Feb 2024012
Mar 20240312
Apr 202401221
May 20240143
Jun 2024096
Jul 20240137
Aug 20240174
Sep 2024076
Oct 202401110
Nov 2024089
Dec 2024041
Jan 2025085
Feb 20250296
Mar 20250137
Apr 202502014
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 56 (8)
Journal of Nuclear Medicine
Vol. 56, Issue 8
August 1, 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reply: Breast Cancer Staging: To Which Women Should 18F-FDG PET/CT Be Offered?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Reply: Breast Cancer Staging: To Which Women Should 18F-FDG PET/CT Be Offered?
Gary A. Ulaner, Christopher C. Riedl
Journal of Nuclear Medicine Aug 2015, 56 (8) 1293-1294; DOI: 10.2967/jnumed.115.161042

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Reply: Breast Cancer Staging: To Which Women Should 18F-FDG PET/CT Be Offered?
Gary A. Ulaner, Christopher C. Riedl
Journal of Nuclear Medicine Aug 2015, 56 (8) 1293-1294; DOI: 10.2967/jnumed.115.161042
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 176Lu Radiation in Long–Axial-Field-of-View PET Scanners: A Nonissue for Patient Safety
  • Business Model Beats Science and Logic: Dosimetry and Paucity of Its Use
  • Reply to “Routine Dosimetry: Proceed with Caution”
Show more Letters to the Editor

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire